DLDongmei Li

Dongmei Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dongmei Li has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Social media-based coordinated care for high-risk stroke populations (COMPLIANCE-MT): A Multicenter Randomized Controlled Trial (Preprint)

    by Dongmei Li

    BACKGROUND A significant gap persists between clinical guidelines and real-world practice regarding medication adherence after discharge. OBJECTIVE We assessed whether a social media-based coordinated care program improves patients’ medication adherence in high-risk stroke populations in China. METHODS We conducted a multicentre, open-label, blinded-endpoint, randomised controlled trial at 33 centres in China. Adult patients at high risk of stroke were randomly assigned (1:1) before discharge, via a central web-based system, to receive social media-based coordinated care or conventional care. The primary outcome was good medication adherence to all guideline-recommended vascular prevention medications at 12 months post-discharge, assessed by a Composite Medical Adherence Score (CMAS). Analyses were conducted according to the intention-to-treat principle. The treatment effect was estimated using binary logistic regression analysis with adjustment for site and baseline prognostic factors. This trial is registered at ClinicalTrials.gov (NCT05963828). RESULTS Between July 19, 2023, and March 29, 2024, 738 patients were randomly assigned to receive conventional care (n=371) or social media-based care (n=367). At 1 year after discharge, 8 of 367 patients in the intervention group and 6 of 371 patients in the control group died before the assessment of the primary outcome, and another 4 (1.1%) (2 in each group) were lost to follow-up. Good medication adherence was significantly higher in the intervention group compared with the control group (88.2% [315/357] vs 82.1% [298/363]; adjusted OR 1.67, 95% CI 1.08 to 2.56; P =0.021). CONCLUSIONS In this multicentre trial conducted in China, a social media-based coordinated care program significantly improved medication adherence at 12 months post-discharge among high-risk stroke populations compared with conventional care. CLINICALTRIAL ClinicalTrials.gov NCT05963828; https://clinicaltrials.gov/study/NCT05963828

  • Open Access

    Chinese Version of the mHealth App Usability Questionnaire for Health Care Providers: Cross-Sectional Translation and Validation Study

    by Mengxia Chen, Wenjun Gao, Yijie Pan, Mengdi Wang, Bing Yu, Dongmei Li, Huanhuan Hu, Jing Zheng, Lingjuan Zhang, Yuan Gao

    Background: With the rapid proliferation of mobile health (mHealth) apps in clinical practice, ensuring their usability for health care providers is critical to optimize workflow integration and service delivery. The mHealth App Usability Questionnaire (MAUQ) is a validated tool for assessing usability, but its applicability in Chinese health care settings remains untested. Cross-cultural adaptation and validation of the MAUQ for interactive apps are essential to address this gap. Objective: This study aimed to translate the MAUQ (for interactive apps for health care providers) into Chinese (MAUQ-C), adapt it to the Chinese health care context, and validate its psychometric properties for future mHealth research and use in China. Methods: This cross-sectional study followed international guidelines for cross-cultural adaptation, including forward translation, backward translation, expert review, and pretesting. A convenience sample of 382 health care providers (eg, physicians and nurses) using mHealth apps was recruited from 2 hospitals in China. Reliability was evaluated using the Cronbach α, test-retest reliability, and split-half reliability. Validity was assessed through content validity index, exploratory factor analysis, and confirmatory factor analysis. Results: The MAUQ-C retained the original 21-item structure and 3 dimensions. Content validity index values ranged from 0.833 to 1.000 (Scale-Content Validity Index/Average=0.992). Exploratory factor analysis identified a 3-factor model explaining 63.48% of the total variance. Confirmatory factor analysis confirmed a good model fit (minimum discrepancy/df=1.810; cumulative fit index=0.950; root-mean-square error of approximation=0.058). The Cronbach α for the total scale was 0.919, with dimension-specific values of 0.928, 0.877, and 0.886. Test-retest reliability was 0.881, and split-half reliability was 0.726. These results confirm that the MAUQ-C effectively measures usability across the dimensions of usability and satisfaction, system information arrangement, and efficiency. Conclusions: The MAUQ-C is a reliable and valid instrument for evaluating mHealth app usability among Chinese health care providers. It can serve as a critical tool to guide the development and optimization of mHealth solutions tailored to the Chinese health care system.

  • Open Access

    Efficacy of Remote Ischemic Conditioning for Moyamoya Disease: A Meta‐Analysis of Randomized Controlled Trials

    by Xiaohong Zheng, Hongliang Liu, Jing Zheng, Xiaojie Li, Yanmei Zu, Tianqi Zhou, Dongmei Li, Jianmin Liu, Li Xu

    Introduction: Remote ischemic conditioning (RIC) is a noninvasive, transient procedure that induces brief ischemia and reperfusion. Currently, an assessment of its efficacy in treating moyamoya disease (MMD) remains lacking. This meta‐analysis synthesized data from existing randomized controlled trials (RCTs) to estimate the efficacy of RIC in MMD patients. Methods: Embase, PubMed, Wanfang, Cochrane Library, Web of Science, Scopus, and CNKI were comprehensively searched from database inception to May 8, 2026. The Cochrane risk of bias tool was used to assess the quality of the included RCTs. Statistical analyses were carried out using Review Manager Version 5.4.1. Results: RIC was associated with a lower incidence of ischemic stroke in patients with MMD ( n = 228, OR: 0.22, 95% CI: 0.07–0.67, p = 0.008). No significant reduction was observed in the incidence of transient ischemic attacks (TIA) ( n = 184, OR: 0.73, 95% CI: 0.36–1.47, p = 0.38), CHS ( n = 152, OR: 0.28, 95% CI: 0.07–1.12, p = 0.07), or seizures ( n = 152, OR: 0.26, 95% CI: 0.04–1.62, p = 0.15). Conclusion: RIC may have potential neuroprotective effects in patients with MMD, particularly regarding ischemic stroke. However, the current evidence remains limited by small sample sizes, sparse events, and substantial heterogeneity. Further adequately powered multicenter RCTs are required to confirm these findings.

  • Open Access

    Chinese Version of the mHealth App Usability Questionnaire for Health Care Providers: Cross-Sectional Translation and Validation Study (Preprint)

    by Mengxia Chen, Wenjun Gao, Yijie Pan, Mengdi Wang, Bing Yu, Dongmei Li, Huanhuan Hu, Jing Zheng, Lingjuan Zhang, Yuan Gao

    BACKGROUND With the rapid proliferation of mobile health (mHealth) apps in clinical practice, ensuring their usability for health care providers is critical to optimize workflow integration and service delivery. The mHealth App Usability Questionnaire (MAUQ) is a validated tool for assessing usability, but its applicability in Chinese health care settings remains untested. Cross-cultural adaptation and validation of the MAUQ for interactive apps are essential to address this gap. OBJECTIVE This study aimed to translate the MAUQ (for interactive apps for health care providers) into Chinese (MAUQ-C), adapt it to the Chinese health care context, and validate its psychometric properties for future mHealth research and use in China. METHODS This cross-sectional study followed international guidelines for cross-cultural adaptation, including forward translation, backward translation, expert review, and pretesting. A convenience sample of 382 health care providers (eg, physicians and nurses) using mHealth apps was recruited from 2 hospitals in China. Reliability was evaluated using the Cronbach α, test-retest reliability, and split-half reliability. Validity was assessed through content validity index, exploratory factor analysis, and confirmatory factor analysis. RESULTS The MAUQ-C retained the original 21-item structure and 3 dimensions. Content validity index values ranged from 0.833 to 1.000 (Scale-Content Validity Index/Average=0.992). Exploratory factor analysis identified a 3-factor model explaining 63.48% of the total variance. Confirmatory factor analysis confirmed a good model fit (minimum discrepancy/df=1.810; cumulative fit index=0.950; root-mean-square error of approximation=0.058). The Cronbach α for the total scale was 0.919, with dimension-specific values of 0.928, 0.877, and 0.886. Test-retest reliability was 0.881, and split-half reliability was 0.726. These results confirm that the MAUQ-C effectively measures usability across the dimensions of usability and satisfaction, system information arrangement, and efficiency. CONCLUSIONS The MAUQ-C is a reliable and valid instrument for evaluating mHealth app usability among Chinese health care providers. It can serve as a critical tool to guide the development and optimization of mHealth solutions tailored to the Chinese health care system. CLINICALTRIAL